RT Journal Article
SR Electronic
T1 Short of Breath for the Long Haul: Diaphragm Muscle Dysfunction in Survivors of Severe COVID-19 as Determined by Neuromuscular Ultrasound
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.12.10.20244509
DO 10.1101/2020.12.10.20244509
A1 Farr, Ellen
A1 Wolfe, Alexis R.
A1 Deshmukh, Swati
A1 Rydberg, Leslie
A1 Soriano, Rachna
A1 Walter, James M.
A1 Boon, Andrea J.
A1 Wolfe, Lisa F.
A1 Franz, Colin K.
YR 2020
UL http://medrxiv.org/content/early/2020/12/11/2020.12.10.20244509.abstract
AB Many survivors from severe coronavirus disease 2019 (COVID-19) suffer from persistent dyspnea and fatigue long after resolution of the active infection. In a cohort of 25 consecutive COVID-19 survivors admitted to an inpatient rehabilitation hospital (76% male), 80% of them had at least one sonographic abnormality of diaphragm muscle structure or function.Specifically, when compared to established normative data, 76% had reduced diaphragm thickening ratio (impaired contractility), and 20% patients had reduced diaphragm muscle thickness (atrophy). These findings support neuromuscular respiratory dysfunction as a highly prevalent underlying cause for prolonged functional impairments after hospitalization for COVID-19.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Study approval was granted by the Northwestern University Institutional Review Board (STU23625789).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe de-identified clinical data presented here will be made available to academic-based medical and health researchers on request.(COVID-19)Coronavirus disease 2019(CK)Creatine Kinase(COPD)Chronic Obstructive Pulmonary Disease(CIM)Critical Illness Myopathy(ACE-2)Angiotensin-Converting Enzyme 2